Welcure Drugs & Pharmaceuticals Ltd — Important, 05-12-2025: Company Update

Welcure Drugs And Pharmaceuticals' Rights Issue Committee meeting, set to finalize key terms such as record date, issue price, and entitlement ratio for its Rights Issue, has been postponed. This delay is due to the company awaiting in-principle approval from the Stock Exchange for the Rights Issue. The committee now plans to convene within one working day of receiving this crucial approval, impacting the timeline for shareholders seeking details on the upcoming Rights Issue.